About Lehe
乐于心,和与众,与己乐,与人和; 心宽念纯,百病无生。
Patient1:“My white blood cell count is low, why doesn't the doctor prescribe a leukocyte-boosting injection for me?”
Patient2:“Leukocyte-boosting injections can deplete white blood cells in advance, so it's better not to use them if possible!”
Chemotherapy and radiotherapy are two major “weapons” for treating tumors. However, while these two treatment methods kill cancer cells, they also cause significant damage to the body's immune system's vital guardians, the white blood cells. Therefore, many patients undergoing chemotherapy and radiotherapy face the choice of “leukocyte-boosting” treatments.

According to survey data, the overall proportion of patients experiencing bone marrow suppression after chemotherapy is 44.2%, which means that approximately one in every two patients undergoing tumor chemotherapy may experience bone marrow suppression1/3 of the time, patients may experience a decrease in multiple blood cell indicators; The proportion of patients with triple-lineage bone marrow suppression, where white blood cells, red blood cells, and platelets all decrease, is 11.2%. This means that more than 1/10 of patients experience a reduction in all blood cells after chemotherapy. [1]
Bone marrow suppression is a significant cause of decreased white blood cell count. Since white blood cells are generated in the bone marrow, both the toxicity of chemotherapy drugs and the damage to bone marrow tissue from radiotherapy radiation can harm hematopoietic stem cells in the bone marrow, leading to bone marrow suppression and a decrease in white blood cell count.
What are the effects of leukopenia?

1、 Complications
White blood cell count below4.0×10 ^ 9/L(adults), especially neutrophils below2
2. Immune system collapse
White blood cells are the "sentinels" against cancer cell recurrence, which can inhibit tumors through immune surveillance and direct killing. The decrease in white blood cells after chemoradiotherapy may activate dormant cancer cells, increasing the risk of cancer metastasis and recurrence.
3. Affecting treatment progress
Some patients have to reduce the dose of chemoradiotherapy or delay the treatment course due to the decrease in white blood cells, which can directly affect the anti-cancer effect and even accelerate tumor recurrence.
Don't just focus on leukogenic injections, there are also these methods
Eating White:



Immune Synergy, the Invisible Driver of Leukocyte Increase
When the immune system functions normally, it can regulate bone marrow hematopoiesis, promote the production of white blood cells, enhance immunity, and improve the activity and function of white blood cells.

Professor Zhang Minghui's research on vNKT cells can indirectly improve the immunosuppression state after chemotherapy by regulating the immune microenvironment and enhancing the body's anti-tumor immune response. Combined use with leukogenic drugs can reduce the dosage of leukogenic drugs, lower the risk of side effects such as bone pain and fever, prolong the recovery period of neutrophils, and reduce the need for repeated injections. In conjunction with the methods of exercise, belief, and positive psychology in Lexin New Medicine's "Four Methods and Eight Directions", immune enhancement can become an invisible boost for leukogenic therapy.
Drug intervention, synergistic approach of traditional Chinese and Western medicine
Drug leukocytosis is one of the effective means to increase the number of white blood cells, playing the role of a "first-aid pioneer" for rapid leukocytosis. Long-acting leukocyte-boosting injections, short-acting leukocyte-boosting injections, and various leukocyte-boosting tablets are overwhelming, making it difficult to choose. When should medication be administered? Are you afraid that leukocyte-boosting drugs will prematurely deplete the body's white blood cells?
Leukopenia is a common challenge on the road to anti-cancer treatment. In terms of treatment goals, leukocytosis treatment is divided into preventive and therapeutic categories. Relying solely on leukocyte-boosting injections and tablets is not the only option. From "eating the right foods" to "using the right drugs", from "single leukocyte-boosting" to "immune synergism", every step is aimed at securing the "golden time" for patients in their fight against cancer.
Remember, developing a personalized plan under the guidance of a doctor is the core of scientific leukocyte elevation.
Lehe Anti-Cancer Ambassador, after breast cancer surgery, 20 years ago, Suihe Teacher also shared her experience in leukocyte elevation.
[1]Mingjian |Research Report on the Current Status of Chemotherapy-Related Myelosuppression and Clinical Management in Chinese Oncology Patients
[2]Fan Xiao,Chang Fangfang,Sun Qiaoyu,Liu Jia,Zhang Yingying,Cui Zhen. The Impact of Nutritional Intervention on the Short-term Efficacy and Adverse Reactions of Patients with Locally Advanced Esophageal Cancer Undergoing Concurrent Chemoradiotherapy [J]. Journal of Bengbu Medical College, 2023, 48(11): 1524-1528.
Immunity science popularization, vegetarian diet, health live broadcasts
Add a virtual assistant and join Professor Zhang's science popularization group to learn together
Founder of Lehe New Medicine
Professor Zhang Minghui, who holds a PhD in Immunology from Tsinghua University School of Medicine, has led a research team for over 20 years since the discovery of vNKT cells in 2002. They have accumulated treatment experience in over 700 cases of solid tumors, covering almost all common solid tumors. The research results fully demonstrate the great value of vNKT in the treatment of solid tumors.

It is suitable for postoperative patients with high pathological malignancy or a risk of recurrence; patients whose tumors have been basically controlled but not cured through conventional treatments such as chemotherapy, radiotherapy, and targeted therapy; patients with persistent high carcinogenic factors; and patients intolerant to radiotherapy and chemotherapy. If these patients do not receive effective follow-up treatment after traditional anti-tumor therapy, recurrence, metastasis, or reoccurrence of tumors will be highly probable. In this case, vNKT cell therapy is an ideal follow-up treatment method, which can significantly improve the prognosis of patients.
Click on the image to view the exciting content from previous issues